Vertex Pharmaceuticals Inc (NAS:VRTX)
$ 465.73 -2.4 (-0.51%) Market Cap: 119.94 Bil Enterprise Value: 115.74 Bil PE Ratio: 0 PB Ratio: 7.68 GF Score: 93/100

Q2 2022 Vertex Pharmaceuticals Inc Earnings Call Transcript

Aug 04, 2022 / 08:30PM GMT
Release Date Price: $274.85 (-0.07%)
Operator

Good day, and welcome to the Vertex Pharmaceuticals Second Quarter 2022 Earnings Call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Charlie Wagner, Chief Financial Officer. Please go ahead.

Charles F. Wagner
Vertex Pharmaceuticals Incorporated - Executive VP & CFO

Good evening. This is Charlie Wagner, Vertex' Chief Financial Officer. Welcome to our second quarter 2022 financial results conference Call.

On tonight's call, making prepared remarks, we have Dr. Reshma Kewalramani, Vertex's CEO and President; Stuart Arbuckle, Chief Operating Officer; and myself. We recommend that you access the webcast slides as you listen to this call. Also, the call is being recorded, and a replay will be available on our website.

We will make forward-looking statements on this call that are subject to the risks and uncertainties discussed in detail in today's press release and in our filings with the Securities and Exchange Commission. These statements including, without

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot